While several studies and reviews have addressed the therapeutic role of riboflavin in specific diseases, few have integrated the metabolic, genetic, and therapeutic aspects of riboflavin across the neurological disease continuum
Although obesity can lead to the development of type 2 diabetes mellitus, dyslipidemia, as well as arterial hypertension [8], obesity alone, even in the absence of these metabolic disorders, can increase the risk for heart failure and ASCVD [9]
Also lets you easily track side effects
Dairy/milk free
These include: Persistent fatigue, cold intolerance, or constipation (suggesting hypothyroidism) Excessive thirst, increased urination, or blurred vision (indicating poor glycaemic control) Abdominal pain, nausea, or vomiting (potential pancreatitis, a rare but serious adverse effect) Right upper quadrant pain, jaundice, pale stools, or dark urine (possible gallbladder disease, which has increased risk with GLP-1 receptor agonists) [1] [2] New visual symptoms including floaters or blurred vision (potential diabetic retinopathy complications) Mood changes, particularly low mood or increased anxiety New or worsening oedema in the legs, ankles, or face Lack of expected weight loss after three to six months at therapeutic doses should also prompt discussion with your healthcare provider
